Good Practice for Introducing Radiopharmaceuticals for Clinical Use

INTERNATIONAL ATOMIC ENERGY AGENCY

IAEA-TECDOC-1782

English IAEA-TECDOC-1782 | 978-92-0-111215-6

80 pages | 6 figures | € 18.00 | Date published: 2015

Download PDF (3.96 MB)

Get citation details

Description

The use of new radiopharmaceuticals can provide extremely valuable information in the evaluation of cancer, as well as heart and brain diseases — information that often times cannot be obtained by other means. However, there is a perceived need in many Member States for a useful reference to facilitate and expedite the introduction of radiopharmaceuticals already in clinical use in other countries. This publication intends to provide practical support for the introduction of new radiotracers, including recommendations on the necessary steps needed to facilitate and expedite the introduction of radiopharmaceuticals in clinical use, while ensuring that a safe and high quality product is administered to the patient at all times.

More Information on reusing IAEA copyright material.

Keywords

Nuclear Medicine, Radiopharmaceuticals, Radioisotopes in Medical Diagnosis, Radiotracers, Health, Quality Control, Good Practice, Clinical Use, Recommendations, Cancer, Member States, Heart Diseases, Patients